Aqsens Health Oy is a Finnish health- and biotechnology startup developing non-invasive screening tests for different high-impact diseases. The company’s current research projects focus on developing a mobile screening platform fit for the needs of developing economies, and establishing a reliable and cost-efficient screening test for prostate cancer. The tests use Aqsens Health’s novel E-TRF technology in combination with bacteriophage-biosensors.